• 1
    Zinkernagel RM. Immunity to viruses. In: PaulWE, ed. Fundamental immunology. New York: Raven, 1993: 12111249.
  • 2
    Hou S, Doherty PC, Zijlstra M, Jaenisch R, Katz JM. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J Immunol 1992; 149: 13191325.
  • 3
    Battegay M, Bachmann MF, Burkhart C, Benoist C, Viville S, Mathis D, Hengartner H. et al. Antiviral immune response of mice lacking MHC class II or its associated invariant chain. Cell Immunol 1996; 167: 115121.
  • 4
    Zinkernagel RM, Welsh RM. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. L Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. J Immunol 1976; 117: 14951502.
  • 5
    Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe TY. et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 65476549.
  • 6
    Garcia-Buey L, Garcia-Monzon C, Rodriguez S, Borque MJ, Garcia-Sanchez A, Iglegias R, DeCastro M. et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995; 108: 17701777.
  • 7
    Hoofnagle JH. Therapy of acute and chronic viral hepatitis. Adv Intern Med 1994; 39: 241275.
  • 8
    Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, Krawczynski K. et al. Volunteer blood donors with antibody to hepatitis C virus: clinical biochemical, virological, and histological features. Ann Intern Med 1995; 123: 330337.
  • 9
    Shindo M, Arai K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology 1995; 22: 418425.
  • 10
    Rice CM, Walker CM. Hepatitis C virus-specific lymphocyte responses. Curr Opinion Immunol 1995; 7: 532538.
  • 11
    Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM. et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus encoded peptides bindinto HLA-A2.1 molecules. J Virol 1995; 69: 24622470.
  • 12
    Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993; 67: 75227532.
  • 13
    Cerny A, Ferrari C, Chisari FV. The class I-restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses. Curr Top Microbiol Immunol 1994; 189: 169186.
  • 14
    Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH. et al. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol 1995; 154: 27332742.
  • 15
    Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL. et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104: 580587.
  • 16
    Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR. et al. Compartimentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178: 1725.
  • 17
    Kurokohchi K, Akatsuka T, Pendleton DC, Takamizawa A, Nishioka M, Battegay M, Feinstone SM. et al. A novel approach for identifying epitopes used to locate a human CTL epitope presented by HLA-A2 in the hepatitis C virus NS3 region. J Exp Med 1995; submitted.
  • 18
    Koskinas J, McFarlane BM, Nouri-Aria KT, Tibbs CJ, Mizokami M, Donaldson PT, McFarlane IG. et al. Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology 1994; 107: 14361442.
  • 19
    Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R. et al. T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and healthy anti-HCV seropositives. Hepatology 1996; 24: 790795.
  • 20
    Schupper H, Hayashi P, Scheffel J, Aceituno S, Paglieroni T, Holland PV, Zeldis JB. Peripheral-blodd mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 1993; 18: 10551066.
  • 21
    Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, Nitschko H. et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21: 632638.
  • 22
    Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C. et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19: 286295.
  • 23
    Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D. et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 10061007.
  • 24
    Milich DR, McLachlan A, Thornton GB, Hughes JL. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 1987; 329: 547549.
  • 25
    Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol 1994; 68: 47004704.
  • 26
    Zinkernagel RM, Moskophidis D, Kundig T, Oehen S, Pircher HP, Hengartner H. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol Rev 1993; 131: 198223.
  • 27
    Paul WE. The immune system: an introduction. In: PaulWE, ed. Fundamental immunology. New York: Raven, 1993: 120.
  • 28
    Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewsky RR, Mushahwar IK. et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135140.
  • 29
    Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A. et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343: 388390.
  • 30
    Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A. et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145: 34423449.
  • 31
    Moskophidis D, Battegay M, van den Broek M, Laine E, Hoffmann-Rohrer U, Zinkernagel RM. Role of virus host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J Gen Virol 1995; 76: 381391.